Somewhat Positive Media Coverage Somewhat Unlikely to Impact Relx (RENX) Stock Price

Media coverage about Relx (NYSE:RENX) has been trending somewhat positive this week, Accern reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Relx earned a news sentiment score of 0.17 on Accern’s scale. Accern also gave media coverage about the technology company an impact score of 46.5169372196778 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

A number of analysts recently commented on the stock. Zacks Investment Research cut shares of Relx from a “buy” rating to a “hold” rating in a research note on Thursday, September 28th. BidaskClub cut shares of Relx from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd.

Relx (NYSE:RENX) traded up $0.08 during mid-day trading on Thursday, reaching $22.97. 33,900 shares of the company were exchanged, compared to its average volume of 83,935. The company has a quick ratio of 0.43, a current ratio of 0.47 and a debt-to-equity ratio of 2.35. Relx has a one year low of $16.30 and a one year high of $23.30.

WARNING: This article was reported by Community Financial News and is owned by of Community Financial News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.com-unik.info/2017/12/28/somewhat-positive-media-coverage-somewhat-unlikely-to-impact-relx-renx-stock-price.html.

About Relx

RELX NV is a holding company, which holds interests in RELX Group plc. RELX Group is a global provider of information and analytics for professional and business customers across industries. The Company operates in four segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal, and Exhibitions.

Insider Buying and Selling by Quarter for Relx (NYSE:RENX)

What are top analysts saying about Relx? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Relx and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit